Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6182735 | Gynecologic Oncology | 2014 | 6 Pages |
Abstract
Permanent interstitial brachytherapy with Cs-131 was well tolerated with favorable early results compared to other series. Cs-131 has multiple favorable properties, including minimal radiation exposure to treating staff, and should be considered as a therapeutic option in appropriately selected patients. A methodology for dose prescription, calculation of radioactivity required and distribution of the isotope is also presented.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Charles Eric Wooten, Marcus Randall, Jason Edwards, Prakash Aryal, Wei Luo, Jonathan Feddock,